NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr | ₹1.10 Cr |
What is the latest Contingent Liabilities ratio of NATCO PHARMA ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹0.40 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹8.00 Cr |
Mar2021 | ₹1.20 Cr |
Mar2020 | ₹1.10 Cr |
How is Contingent Liabilities of NATCO PHARMA Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹0.40 Cr | -97.26 | |
Mar2023 | ₹15 Cr | 82.50 | |
Mar2022 | ₹8.00 Cr | 566.67 | |
Mar2021 | ₹1.20 Cr | 9.09 | |
Mar2020 | ₹1.10 Cr | - |
Compare Contingent Liabilities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹17,436.3 Cr | 10.2% | 13.4% | -23.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | -0.6% | 0.8% | 10.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.1% | 3.8% | 49.2% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | 0.4% | 2.5% | 1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | -0.2% | 6.4% | 20.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -0.6% | 3.3% | 0.1% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 10.2% |
13.4% |
-23.1% |
SENSEX | -0.6% |
3.1% |
5.3% |
You may also like the below Video Courses